Founded in New York, Protheragen Inc. is a biopharmaceutical incubator that helps turn early-stage drug discoveries into commercial assets. Its integrated approach combines project incubation, early-stage capital support and cross-border business-development consulting, linking scientists and pharmaceutical companies with international partners. The company says it has more than 18 years of industry experience and has managed over 130 projects, with a particular focus on oncology programs.